POPULATION CHARACTERISTICS OF BIOLOGICAL-SYSTEMS INFLUENCED BY MULTICOMPONENT RANDOM AND UNIFORM VARIATION

被引:3
作者
KOCHAK, GM
机构
[1] Drug Development Department, Pharmaceuticals Division, CIBA-GEIGY Corporation, Ardsley, New York, 10502
关键词
MIXED-EFFECTS ANALYSIS OF VARIANCE; RANDOM EFFECTS; FIXED EFFECTS; INTRASUBJECT VARIANCE; INTERSUBJECT VARIANCE; DIURNAL VARIANCE;
D O I
10.1023/A:1015838802045
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The total variability associated with the pharmacokinetic disposition of seven therapeutic agents was decomposed into its source components. After differentiating and isolating random components from fixed uniform components of variance, the proportional contribution of random intersubject and intrasubject variance was evaluated. Statistical analysis utilized a mixed-effects probabilistic model which incorporated both random effects and fixed day-to-day effects. In some cases, time-within-day diurnal effects were also incorporated. While significant intersubject effects were found for all seven drugs studied, three of them were characterized by predominant intrasubject variance. Since intrasubject variance represents a measure of the stability of drug disposition, characterization of its relative magnitude is fundamentally important in assessing the therapeutic consequences of a given treatment at any given time. Significant diurnal effects were found which were strikingly invariant.
引用
收藏
页码:345 / 349
页数:5
相关论文
共 13 条
[1]   STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE INTWINS - INFLUENCE OF GENETIC FACTORS AND DRUG THERAPY [J].
ALEXANDERSON, B ;
EVANS, DAP ;
SJOQVIST, F .
BMJ-BRITISH MEDICAL JOURNAL, 1969, 4 (5686) :764-+
[2]   INTRAINDIVIDUAL VARIATION IN DRUG DISPOSITION [J].
ALVARES, AP ;
KAPPAS, A ;
EISEMAN, JL ;
ANDERSON, KE ;
PANTUCK, CB ;
PANTUCK, EJ ;
HSIAO, KC ;
GARLAND, WA ;
CONNEY, AH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) :407-419
[3]  
BOURGEOIS BFD, 1984, THER DRUG MONIT, V6, P259, DOI 10.1097/00007691-198409000-00001
[4]   CARBAMAZEPINE METABOLISM IN MAN INDUCTION AND PHARMACOGENETIC ASPECTS [J].
EICHELBAUM, M ;
TOMSON, T ;
TYBRING, G ;
BERTILSSON, L .
CLINICAL PHARMACOKINETICS, 1985, 10 (01) :80-90
[5]   DIFFERENCES IN ORAL VERAPAMIL ABSORPTION AS A FUNCTION OF TIME OF DAY [J].
ELDON, MA ;
BATTLE, MM ;
VOIGTMAN, RE ;
COLBURN, WA .
JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (11) :989-993
[6]  
FLUEHLER H, 1981, J PHARMACOKINET BIOP, V9, P235
[7]   COMPARATIVE BIOAVAILABILITY OF TRAZODONE FORMULATIONS USING STABLE ISOTOPE METHODOLOGY [J].
GAMMANS, RE ;
MACKENTHUN, AV ;
RUSSELL, JW .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (03) :431-437
[8]   CHRONOPHARMACOKINETIC STUDY OF A PROLONGED RELEASE FORM OF INDOMETHACIN [J].
GUISSOU, P ;
CUISINAUD, G ;
LLORCA, G ;
LEJEUNE, E ;
SASSARD, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (05) :667-670
[9]   SINGLE-DOSE PHARMACOKINETICS OF TERODILINE, INCLUDING A STABLE ISOTOPE TECHNIQUE FOR IMPROVEMENT OF STATISTICAL EVALUATIONS [J].
HALLEN, B ;
GUILBAUD, O ;
STROMBERG, S ;
LINDEKE, B .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1988, 9 (03) :229-250
[10]   INTRASUBJECT AND INTERSUBJECT VARIABILITY - MIXED-EFFECTS STATISTICAL-ANALYSIS OF REPEATED DOSES OF AN ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, CGS-16617 [J].
KOCHAK, GM ;
SMITH, RA ;
CHOI, RL ;
JOHN, V ;
TIPNIS, V ;
HONC, F ;
DESILVA, JK ;
WEIDLER, DJ .
PHARMACEUTICAL RESEARCH, 1989, 6 (04) :328-331